Molecular Imaging

FDA accepts Lantheus’ NDA for new Pylarify formulation

By AuntMinnie.com staff writers

The U.S. FDA has accepted a new drug application (NDA) for a new formulation of Pylarify, Lantheus's prostate cancer PET imaging agent.

August 6, 2025

Is imaging being used to its full potential to diagnose dementia?

By Kate Madden Yee

As disease-modifying therapies for various types of dementia become more available, MR and CT imaging predominate for diagnosis.

August 6, 2025

New Lantern launches mammography, PET/CT viewer modes

By AuntMinnie.com staff writers

New Lantern has expanded its AI-powered radiology platform with two new viewer modes for mammography and PET/CT.

August 5, 2025

PET/CT reliable for diagnosing fracture-related infections

By Will Morton

PET/CT identified infections in almost half of patients.

August 4, 2025

Amyloid PET scans validated in racially diverse patients

By Will Morton

Changes in care plans occurred in 59% of individuals after PET scans.

August 1, 2025

SNMMI highlights radioimmunotherapy study

By AuntMinnie.com staff writers

The study lays the foundation for development of radionuclide therapies targeting cancer stem cells.

July 30, 2025

Siemens reports revenue uptick in Q3

By AuntMinnie.com staff writers

The company reported a revenue increase of 7.6% over the same period last year.

July 30, 2025

GE HealthCare posts revenue increase in Q2

By AuntMinnie.com staff writers

The company reported a 3% increase in revenue in its second quarter of 2025.

July 30, 2025

Visual reads of amyloid PET scans effective in real-world settings

By Will Morton

The findings support the use of amyloid PET scans as acquired and visually read in the real world.

July 28, 2025

Shimadzu gets FDA authorization for head and breast PET scanner

By AuntMinnie.com staff writers

Shimadzu has obtained U.S. Food and Drug Administration (FDA) premarketing authorization for its PositView SET-5002 PET system.

July 25, 2025

Brain PET tracer delivered intranasally for first time in humans

By Will Morton

The study confirms the safety and efficacy of Ga-68 NOTA-insulin as a PET radiotracer that can be used for human neuroimaging.

July 24, 2025

Lantheus completes Life Molecular Imaging acquisition

By AuntMinnie.com staff writers

Life Molecular Imaging's CEO Ludger Dinkelborg, PhD, will become head of research and development for Lantheus.

July 22, 2025

Page 1 of 611

Next Page